Selskabets formål er at forske, udvikle og tilvejebringe lægemidler.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -2.2 mio. | -4.3 mio. | 7.6 mio. | -7 mio. | 2 | |
CVR: 41120495
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Hans Thalsgård Schambye joined as ADM. DIR.
Ingelise Saunders left as ADM. DIR.
registered with 100% ownership
Hans Thalsgård Schambye joined the board
Companies in the same industry and area
companydata.dk